Recipharm Launches Serialization Line
By

By
Recipharm, a contract development and manufacturing organization, has launched a showcase line for serialization offering pharmaceutical companies the chance to view and trial its solution to the new European Union…

MabPlex Expands cGMP Manufacturing Facilities
By

By
MabPlex International, a Fremont, California-based contract research and manufacturing organization, has broken ground on the expansion of its biomanufacturing facilities in China. The current 275,000-square-foot facility will soon be running…

Catalent, Triphase Partner to Advance Antibody Drug Conjugate
By

By
Catalent has entered into an agreement with Triphase Accelerator Corporation, a Toronto-based company acquiring and developing cancer therapeutics, in which Triphase will obtain worldwide rights to further develop Catalent’s proprietary…

Quintiles, IMS Complete Merger
By

By
Quintiles IMS Holdings has completed its previously announced merger between IMS Health Holdings, a pharmaceutical market information and technology provider, and Quintiles Transnational Holdings, a contract research organization. The companies…

GE Healthcare Opens $7.4 Million Bioprocessing Center in Korea
By

By
GE Healthcare’s Life Sciences business has opened its new GE Fast Trak Center in Songdo, Incheon Metropolitan City, in South Korea, with an investment of $7.4 Million. The center will provide…

AB BioTechnologies Adds Preclinical Manufacturing
By

By
AB BioTechnologies, a contract service provider based in Bloomington, Indiana, has expanded its services to include preclinical manufacturing at its Bloomington facility, allowing it to execute projects on both the…

ABEC Completes Bulk Biologics Installation at Regeneron Facility
By

By
ABEC, a Bethlehem, Pennsylvania-based engineering, equipment, and services provider, has completed the installation of a bulk biologics manufacturing process in Regeneron Pharmaceuticals’ site in Raheen, County Limerick, Ireland. The first…

BI, Sarah Canon Research Institute Partner in Immuno-Oncology
By

By
Boehringer Ingelheim (BI) has formed a collaboration with the Sarah Cannon Research Institute, the research arm of Nashville, Tennessee-based Sarah Cannon,a global cancer institute of the Hospital Corporation of America,…

Teva Completes $500 Million Acquisition of Anda Inc.
By

By
Teva Pharmaceutical Industries has completed its previously announced acquisition of Anda Inc, a US-based distributor of generic pharmaceuticals, from Allergan. Teva had announced that it was acquiring Anda Inc. for…

Astellas, Maruho Sign Agreement for Skin Disease Therapy
By

By
Astellas Pharma has signed an exclusive license agreement with Maruho, an Osaka, Japan-based pharmaceutical company, for peficitinib, a Janus kinase inhibitor developed by Astellas in a topical formulation for treating…